EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pulmatrix's enterprise value is $-2.97 Mil.
Pulmatrix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7.30 Mil. Therefore, Pulmatrix's EV-to-Revenue for today is -0.41.
The historical rank and industry rank for Pulmatrix's EV-to-Revenue or its related term are showing as below:
PULM'
s EV-to-Revenue Range Over the Past 10 Years
Min: -37.34 Med: 0.93 Max: 228.16
Current: -0.41
During the past 12 years, the highest EV-to-Revenue of Pulmatrix was 228.16. The lowest was -37.34. And the median was 0.93.
PULM's EV-to-Revenue is ranked better than 92.45% of 1033
companies
in the Biotechnology industry
Industry Median: 7.66
vs PULM: -0.41
As of today (2024-04-28), Pulmatrix's stock price is $2.04.
Pulmatrix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.00. Therefore, Pulmatrix's PS Ratio for today is 1.02.
Pulmatrix EV-to-Revenue Historical Data
The historical data trend for Pulmatrix's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pulmatrix's EV-to-Revenue
For the Biotechnology subindustry, Pulmatrix's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulmatrix's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pulmatrix's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pulmatrix's EV-to-Revenue falls into.
Pulmatrix's current Enterprise Value is $-2.97 Mil.
Pulmatrix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulmatrix's share price for today is $2.04.
Pulmatrix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulmatrix EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pulmatrix's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PULM has been successfully added to your 